http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103613591-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C29-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C51-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2013-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103613591-B |
| titleOfInvention | As the compound and its production and use of cMet inhibitor |
| abstract | The present invention relates to the replacement 1H-pyrrolo-[2 as cMet inhibitor, 3-b] pyridine and replace 1H-pyrazolo [3,4-b] pyridine compounds and their and its production and use, the compound of formula (I) and pharmacy acceptable salt thereof, prodrug and solvate and preparation method thereof, wherein Xn 1 , Xn 2 , Xn 3 , Xn 4 , W, Rn 2 , R1n a-e as in specification sheets define.The invention also discloses the preparation method of formula (I) compound and comprise the pharmaceutical composition of described compound.n 。 |
| priorityDate | 2012-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.